Receptor signaling: When dimerization is not enough

Activation of receptors that signal via tyrosine kinase domains has been thought to involve receptor dimerization and transphosphorylation of juxtaposed catalytic domains. Recent results suggest things might be more complex - specific intersubunit conformational changes within a dimer can also be important.

[1]  D. Engelman,et al.  Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation , 1997, Oncogene.

[2]  C. Heldin,et al.  Dimerization of cell surface receptors in signal transduction , 1995, Cell.

[3]  W. Alexander,et al.  Point mutations within a dimer interface homology domain of c‐Mpl induce constitutive receptor activity and tumorigenicity. , 1995, The EMBO journal.

[4]  D. Weiner,et al.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation , 1989, Nature.

[5]  B. Bormann,et al.  Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor , 1996, Nature Structural Biology.

[6]  Ronald W. Barrett,et al.  Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.

[7]  L S Mulcahy,et al.  Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. , 1998, Biochemistry.

[8]  Robert M. Stroud,et al.  Efficiency of signalling through cytokine receptors depends critically on receptor orientation , 1998, Nature.

[9]  D. Baccanari,et al.  Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. , 1997, Science.

[10]  Wen He,et al.  An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activation , 1998, Nature Structural Biology.

[11]  S. Chervitz,et al.  Molecular mechanism of transmembrane signaling by the aspartate receptor: a model. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  I. Wilson,et al.  Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. , 1999, Science.

[13]  M. Sternberg,et al.  A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization. , 1990, Protein engineering.

[14]  H. Lodish,et al.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization , 1994, Molecular and cellular biology.

[15]  S R Sprang,et al.  Structures of the extracellular domain of the type I tumor necrosis factor receptor. , 1996, Structure.

[16]  T. Arakawa,et al.  Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. , 1996, Biochemistry.

[17]  I. Wilson,et al.  Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.

[18]  Enrico A. Stura,et al.  Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å , 1996, Science.

[19]  J G Gleason,et al.  A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. , 1998, Science.

[20]  D. Chang,et al.  Activation of the Erythropoietin (EPO) Receptor by Bivalent Anti-EPO Receptor Antibodies* , 1996, The Journal of Biological Chemistry.

[21]  D. Goeddel,et al.  Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. , 1999, Science.

[22]  A. D. de Vos,et al.  Structural basis for cytokine hormone-receptor recognition and receptor activation. , 1998, Advances in protein chemistry.

[23]  D. Stern,et al.  Activation of Neu (ErbB-2) Mediated by Disulfide Bond-Induced Dimerization Reveals a Receptor Tyrosine Kinase Dimer Interface , 1998, Molecular and Cellular Biology.

[24]  S R Sprang,et al.  Crystallographic Evidence for Dimerization of Unliganded Tumor Necrosis Factor Receptor (*) , 1995, The Journal of Biological Chemistry.

[25]  E. Van Obberghen,et al.  Signalling through the insulin receptor and the insulin-like growth factor-I receptor. , 1994, Diabetologia.